Buy S-4 (Andarine) Capsules

Buy S-4 (Andarine) Capsules

$38.00

S-4 (Andarine) Capsules for sale

S-4 Capsules, also known as Andarine, are a research chemical belonging to the class of selective androgen receptor modulators (SARMs). The chemical name for S-4 is (2S)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide, and it is typically available in capsule form for easy and convenient administration.

Lower fat percentages, more power, that’s what you want! With Next lvl muslce S-4 andarine you too will get the muscular look that many bodybuilders aspire to. Andarine ensures that your muscle mass increases significantly, while body fat decreases. The androgenic effect also increases the power in your muscles.

 

  • Andarine 25mg x 60 capsules
  • Preserves and improves lean body mass during diet phases
  • Increases the oxidation of adipose tissue

Description

Premium S-4 (Andarine) Capsules – Industrial Grade Research Chemical

 

Product Details Table

Attribute Specification
Brand BioSynLab Research Compounds
Product Name S-4 (Andarine)
Synonyms Andarine, GTX-007, S4, Acetamidoxolutamide
CAS Number 401900-40-1
Molecular Formula C₁₉H₁₈F₃N₃O₆
Molecular Weight 441.36 g/mol
Chemical Class Selective Androgen Receptor Modulator (SARM) – First Generation
Purity ≥99.0% (HPLC Verified)
Dosage Form Hard Gelatin Capsules
Unit Dose 25mg, 50mg, or 75mg (custom available)
Capsule Size Size 3 (25mg), Size 1 (50mg), Size 0 (75mg)
Capsule Color Yellow opaque (25mg), Orange/White (50mg), Orange (75mg)
Fill Weight 150-350mg (API + excipients)
Excipients Microcrystalline cellulose, Magnesium stearate, Silicon dioxide
Packaging HDPE bottles (30, 60, 90 count) or blister packs
Storage 2-25°C, Desiccated, Light Protected
Shelf Life 24 months (sealed container)
Documentation COA, HPLC, NMR, MS, MSDS, Stability Data
Shipping Ambient Temperature, Discrete
Origin EU/GMP Certified Laboratory

S-4 (Andarine) Capsules | First-Generation SARM for Androgen Receptor Research | BioSynLab

BioSynLab presents pharmaceutical-grade S-4 (Andarine) in convenient capsule formulation for advanced androgen receptor researchpartial agonist studies, and comparative SARM pharmacology. As one of the first non-steroidal SARMs developed, Andarine serves as a critical historical reference compound for investigating tissue-selective androgen signalingpartial agonist mechanisms, and off-target receptor interactions in laboratory settings.

Chemical Architecture & First-Generation SARM Design

S-4 (Andarine, GTX-007) represents the aryl propionamide class of first-generation SARMs, featuring a distinctive structural scaffold that established the foundation for subsequent SARM development:

Structural Features:

  • Aryl Propionamide Core: Non-steroidal backbone with anabolic activity
  • Cyanonitro Substitution: Electron-withdrawing groups optimizing receptor binding
  • Trifluoromethyl Group: Metabolic stability enhancement
  • Hydroxyl Moiety: Hydrogen bonding capability with AR ligand-binding domain

Mechanism of Action:

  • Androgen Receptor Partial Agonist: Lower intrinsic activity than full agonists (testosterone, DHT)
  • Tissue-Selective Activity: Anabolic effects in muscle and bone with reduced prostate stimulation
  • Binding Affinity: Ki ~4 nM (moderate affinity vs. newer SARMs)
  • Metabolism: Extensive first-pass hepatic metabolism to active metabolites

Physicochemical Properties:

  • Molecular weight: 441.36 g/mol (higher than LGD-4033)
  • Calculated LogP: 2.8 (moderate lipophilicity)
  • pKa: Non-ionizable (neutral molecule)
  • Melting point: 70-75°C (amorphous solid tendency)
  • Chirality: Single enantiomer (chiral center in propionamide)

Capsule Formulation & Pharmaceutical Engineering

Our S-4 capsules utilize precision formulation technology:

Excipient Composition:

  • Active Pharmaceutical Ingredient: S-4 – 25mg, 50mg, or 75mg
  • Diluent: Microcrystalline cellulose (Avicel PH-102) – 100-250mg
  • Glidant: Silicon dioxide (Aerosil) – 2-5mg
  • Lubricant: Magnesium stearate – 2-3mg

Capsule Specifications:

Strength Capsule Size Fill Weight Color Code
25mg Size 3 ~150mg Yellow opaque
50mg Size 1 ~220mg Orange/White
75mg Size 0 ~280mg Orange

Quality Attributes:

  • Content uniformity: RSD <6% (USP <905>)
  • Weight variation: Meets USP <905> criteria
  • Disintegration: <30 minutes (USP <701>)
  • Dissolution: >75% in 45 minutes

Packaging Options:

  • HDPE bottles: 30, 60, 90 count with desiccant canister
  • Blister packs: 10 capsules per sheet, child-resistant
  • Bulk packaging: 500, 1000 count for institutional orders

Analytical Characterization & Quality Verification

Each BioSynLab S-4 batch undergoes comprehensive analytical profiling:

Chromatographic Analysis:

  • HPLC-UV (220nm): ≥99.0% purity
  • Chiral HPLC: Enantiomeric purity >99% ee
  • Related substances: <1.0% total impurities
  • Residual solvents: Meets ICH Q3C

Mass Spectrometry:

  • LC-MS/MS: [M+H]⁺ at m/z 442.1, characteristic fragmentation
  • High-Resolution MS: Exact mass <5 ppm deviation

Nuclear Magnetic Resonance (NMR):

  • ¹H NMR (500MHz, DMSO-d₆):
    • Aromatic protons: δ 6.8-8.0 (m, 8H)
    • Propionamide CH: δ 3.45 (m, 1H)
    • Hydroxyl: δ 5.95 (br s, 1H)
    • CF₃: δ Not observed (¹⁹F NMR)
  • ¹⁹F NMR: Single signal at δ -61.8 ppm
  • ¹³C NMR (125MHz): 19 distinct carbon signals
  • FTIR: O-H (3400 cm⁻¹), C=O (1660, 1680 cm⁻¹), C-F (1120 cm⁻¹), NO₂ (1550 cm⁻¹)

Physical Testing:

  • Water content: <0.5% (Karl Fischer)
  • Heavy metals: <10 ppm (ICP-MS)
  • Specific rotation: [α]²⁰D = -15° to -19° (c=1, methanol)
  • Residue on ignition: <0.1%

Research Applications & Scientific Significance

S-4 capsules serve critical functions in multiple research disciplines:

Androgen Receptor Pharmacology:

  • Partial agonist characterization (intrinsic activity studies)
  • Tissue-selective gene expression (muscle vs. prostate)
  • Coactivator recruitment differences (vs. full agonists)
  • Historical SARM comparison (first-gen vs. second-gen)

Off-Target Research:

  • Ocular receptor binding (vision side effect mechanism)
  • Retinal pigment epithelium studies
  • Night vision impairment modeling
  • Selectivity improvement research (driving development of newer SARMs)

Musculoskeletal Research:

  • Muscle atrophy models (cancer, disuse, aging)
  • Bone density studies (osteoporosis models)
  • Fracture healing research
  • Comparison with LGD-4033/MK-2866

Metabolic Studies:

  • Body composition analysis
  • Lipid profile effects (HDL/LDL changes)
  • Insulin sensitivity research
  • Energy expenditure quantification

Historical & Comparative Research:

  • First-generation SARM benchmark
  • Structure-activity evolution (S-4 → Ostarine → Ligandrol)
  • Clinical discontinuation rationale studies (vision effects)
  • Regulatory development impact

Global Distribution & Discrete Procurement

BioSynLab provides secure, compliant distribution:

Packaging Specifications:

  • Primary: Hard gelatin capsules in HDPE bottles or blister packs
  • Secondary: Tamper-evident sealsdesiccant chambers
  • Tertiary: Discrete unmarked shipping containers

Shipping Options:

  • Standard: Ambient temperature, 5-7 days
  • Express: Tracked courier, 2-3 days
  • Discrete: No product identifiers, generic return addresses

Service Coverage:

United Kingdom: London, Manchester, Birmingham, Leeds, Glasgow, Liverpool, Sheffield, Bristol, Edinburgh, Cardiff, Belfast, Nottingham, Leicester.

European Union: Berlin, Hamburg, Munich, Cologne, Frankfurt, Amsterdam, Rotterdam, Paris, Lyon, Barcelona, Madrid, Rome, Milan, Vienna, Brussels, Prague, Warsaw.

North America: New York, Los Angeles, Chicago, Houston, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Toronto, Vancouver.